A B S T R A C T We previously developed an in vitro organ culture system in which gluten exerts a toxic effect on intestinal mucosa of patients with active gluten-sensitive enteropathy. Gluten generally inhibits the epithelial cell maturation of intestinal biopsy specimens that otherwise occurs if the tissue is cultured for 24-48 h in a gluten-free medium. However, small intestinal mucosa from 15-20% of patients with proven gluten-sensitive enteropathy fails to manifest the expected gluten-induced damage in vitro. In the present study, we explored the relation between in vitro gluteninduced intestinal damage and the presence of HLA-B8.
A B S T R A C T We previously developed an in vitro organ culture system in which gluten exerts a toxic effect on intestinal mucosa of patients with active gluten-sensitive enteropathy. Gluten generally inhibits the epithelial cell maturation of intestinal biopsy specimens that otherwise occurs if the tissue is cultured for 24-48 h in a gluten-free medium. However, small intestinal mucosa from 15-20% of patients with proven gluten-sensitive enteropathy fails to manifest the expected gluten-induced damage in vitro. In the present study, we explored the relation between in vitro gluteninduced intestinal damage and the presence of HLA-B8.
We determined whether the patients' histocompatibility type (HLA-B8 positive or negative) influenced the ability of gluten protein to inhibit epithelial cell maturation of cultured intestinal biopsy specimens from patients with gluten-sensitive enteropathy.
Intestinal biopsies from 21 of 24 patients with gluten-sensitive enteropathy and HLA-B8 showed gluteninduced dacmage in vitro. On the other hand, intestinal biopsies from only 4 of 16 patients with gluten-sensitive enteropathy I)ut without HLA-B8 showed gluteninduced daimage in vitro. The difference in the effect of gluten in vitro between these two groups was statistically significant (P < 0.01). The data show a dichotomy between gluten-induced tissue damage in vivo and in vitro in HLA-B8 negative patients, suggesting that
INTRODUCTION
We previously established an in vitro model of glutensensitive enteropathy (GSE)l using organ culture techniques (1) . The model depends upon the fact that (a) intestinal brush border alkaline phosphatase enzyme activity in smiall intestinal tissue obtained from patients with active GSE is low, reflecting altered mucosal architecture and impaired epithelial cell maturation; (b) during organ culture ofthe intestinal tissue in a glutenfree medium, there is a dramatic increase in alkaline phosphatase enzyme activity accompanied by morphologic maturation of epithelial cells; and (c) during culture of the intestinal tissue in a gluten-containing medium, brush border alkaline phosphatase activity does not increase appreciably and cells do not show morphologic evidence of maturation. Thus, inhibition of brush border alkaline phosphatase increase in vitro is an indication of gluten toxicity in vitro, just as the characteristic mucosal lesion is an indication of gluten toxicity in vivo.
In prior experiments, in vitro gluten sensitivity did not always correlate with in vito gluten sensitivity (2). We noted that in studies of 15-20% of patients, regardless of the presence of gluten protein in culture, no inhibition of brush border alkaline phosphatase enzyme increase occurred. No adequate explanation exists for this observation.
In view ofthe known association of GSE with certain histocompatibility antigens (HLA-B8, HLA-DW3), (3) (4) (5) (6) , we determined in the present study whether the deleterious effect of gluten in vitro is restricted by the patient's histocompatibility type. Accordingly, we examined small intestinal tissue from patients with GSE who were positive or negative for HLA-B8 and determined the susceptibility of the tissue in vitro to the cytotoxic effect of gluten protein. The data developed allow the conclusion that histocompatibility antigens are important to the process by which gluten causes epithelial cell cytotoxicity in GSE.
METHODS
Mucosal tissue from HLA-B8 positive and negative patients with GSE were compared as to their susceptibility to gluteninduced toxicity in vitro. Small intestine tissue obtained from disease and normal control individuals was also studied. Gluten toxicity in vitro was determined by the previously described organ culture technique (1) . To determine whether the magnitude of any given difference between alkaline phosphatase values in gluten-containing and gluten-free cultures was indicative of gluten-induced toxicity, a statistical function derived in a previous study from a population of 39 patients with a flat mucosal lesion was used. 26 patients had GSE and 13 did not (2 Study group. 40 patients with GSE, aged 11 mo-52 yr were studied. At the time of biopsy, the patients were either newly diagnosed and, therefore, on no dietary gluten restriction, or had previously defined GSE and were prepared for study by ingestion of gluten for at least 7 d before the study. The initial diag'nosis was firmly established in all patients by the presence of diarrhea or malabsorption, typical appearance of small intestinal histology with total or subtotal villus flattening, infiltration of the lamina propria with lymphocytes and plasma cells, and vacuolization of the epithelial cells. All patients had appropriate response to gluten withdrawal and gluten challenge with remission and exacerbation, respectively, of clinical and laboratory features. The control group consisted of (a) 8 normal individuals with no history of gastrointestinal disease and normal intestinal morphology, (b) 12 patients with diarrhea not due to GSE and normal small bowel morphology, and (c) 15 patients with diarrhea and abnormal small bowel morphology not due to GSE. The latter patients included three with eosinophilic gastroenteritis, two with tropical sprue, five with hypogammaglobulinemia, three with chronic diarrhea of infancy, and two with cow's milk allergy. All patients, including those in the control groups, were eating a gluten-containing diet at the time of study. All individuals under the age of 18 in this study were being evaluated for malabsorption and/or diarrhea and underwent intestinal biopsies as part of a standard assessment. Informed consent was obtained from all individuals studied or their parents. These studies were approved by the Human Studies Committee of the Peter Bent Brigham Hospital Division, Affiliated Hospitals Center, Inc., the Children's Hospital Medical Center, and the National Institutes of Health Clinical Center.
Biopsy technique. A multi-purpose suction biopsy instrument, positioned fluoroscopically at the ligament of Treitz, was used to obtain specimens of jejunal tissue (8) . Three or four biopsy specimens were routinely obtained and a portion of at least one specimen was sent for histological examination.
Organ culture. Biopsies were transported to the laboratory in iced RPMI 1640 medium with 10% fetal calfserum, insulin, and antibiotics. Each biopsy was cut into six to eight pieces, resulting in as many as 30 specimens, which were then thoroughly mixed. Three of these randomized specimens were placed villus-side-up on stainless steel wire mesh grids suspended over culture medium in culture dishes, thus insuring representation on the culture plate from each biopsy. The dishes were placed into closed containers, gassed with 95% oxygen and 5% carbon dioxide mixture, and incubated for 24-48 h at 37°C (1). Where indicated, one oftwo gluten preparations was added to the culture medium (see below). Culture specimens were removed from the culture dish grids at 24-48 h and homogenized in 1 ml of 0.9% saline. Samples were assayed immediately or stored at -80°C until assayed.
Tissue protein (9) and alkaline phosphatase activity (10) (11) . After digestion, pepsin and trypsin were inactivated by heating at 56°C for 1 h. The digest was added to cultures at a concentration of 1 mg/ml. A purified gliadin protein fraction was prepared and added to the cultures to obtain a concentration of 0.1 mg/ml; this protein is an a-gliadin fraction from "Scout 66" wheat and is called A-gliadin (12) . Both PT and a-gliadin exert a similar effect on tissue from patients with active GSE (1). HLA typing. HLA-A and B locus antigens were determined by the National Cancer Institute Histocompatibility Typing Center, using a lymphocyte microcytotoxicity method previously described (13) . Sera used to detect HLA antigens were obtained from the Serum Blood Bank maintained by the Transplantation and Immunology Branch of the National Institute of Allergy and Infectious Diseases, and from
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Falchuk, Nelson, Katz, Bernardin, Kasarda, Hague, and Strober the Serum Collection of the Typing Center. The reproducibility of the assay when replicate determinations were done on normal individuals was 97%. Normal HLA frequencies were determined by the study of random Caucasian blood bank donors. Presence or absence of HLA-D locus antigen, DRW3, was determined on eight patients using a previously described cytotoxicity assay (in conjunction with a specific antiserum for DRW3, kindly provided by Dr. J. J. Van Rood) (14) . Statistical analysis. The Wilcoxon rank-sum test was used to compare the base-line alkaline phosphatase activity in HLA-B8 positive and negative GSE groups. One-way analysis of variance was used to determine the significance of differences among all groups.
RESULTS

HLA types
A and B locus. 24 patients (60%) with GSE were HLA-B8 positive and 16 (40%) were HLA-B8 negative. The frequency of HLA-B8 in this group of patients with GSE was somewhat lower than that previously reported by us and others (3) (4) (5) because non-B8 patients were selected for study to equalize the size of the experimental groups. Such selections were made without prior knowledge of the patient's reactivity in organ culture.
DRW3 locus. Eight patients with GSE were studied for the presence of DRW3. Four of four HLA-B8 positive and three of four B8 negative patients were DRW3 positive. Thus, in this patient group, DRW3 has the same prevalence in B8 positive and B8 negative patients, as previously pointed out by Keunig et al. (6) .
Organ culture studies
In previous studies, we showed that gluten sensitivity in vitro was demonstrable only in patients with active GSE and not in patients with inactive GSE. To make a meaningful comparison between HLA-B8 positive and B8 negative patients, it was, therefore, necessary to ensure that both groups of GSE patients had equivalent activity of disease. To this end, the HLA-B8 positive and B8 negative patients were compared with respect to intestinal alkaline phosphatase activity and jejunal morphology at the moment of biopsy. With regard to the former, we found that mean alkaline phosphatase values (+SD) for B8 positive and B8 negative patients were 73+60 and 112+90, respectively. These values were statistically indistinguishable (P > 0.1) and are both lower than the mean enzyme value for normals in our laboratory (350+75). With regard to jejunal morphology, we examined biopsies without foreknowledge of their source and found no significant difference between B8 positive and B8 negative patients: all biopsies had total or subtotal villus flattening and there was an equal amount of epithelial cell vacuolization and inflammation in the lamina propria of both groups. On the basis of these two objective features, it was concluded that B8 positive and B8 negative patients had equivalent levels of disease activity and could be expected to react to gluten in vitro. (Table III) . Thus, as previously noted (2), intestinal tissue which is abnormal because of causes other than GSE may, in a small fraction of cases, be subjected to nonspecific toxic injury by gluten in vitro.
Patients with diarrhea and normal small bowel biopsy
Biopsy specimens from 12 patients with diarrhea and normal small bowel histology were placed into organ culture: six with A-gliadin and six with PT digest (Table IV) .
Normal individuals
Biopsy specimens from eight normal subjects were placed into organ culture, three with A-gliadin and five with PT digest in the culture medium. Significant inhibition of alkaline phosphatase activity increases by gluten protein in organ culture, as indicated by positive Z values, was not observed in any case (Table V) . In summary, the correct classification rates in the GSE groups by A-gliadin and PT digest, respectively, were: 91% and 88% in the B8 positive group; and 14% and 33% in the B8 negative group (Fig. 1) .
DISCUSSION
We previously showed that when evaluated prospectively, gluten sensitivity in vitro correlates with gluten sensitivity in vivo in most, but not all, instances. A prepare Frazer fraction III) is likely to be only partial.
On this basis, it is possible that B8 positive GSE tissue and B8 negative GSE tissue differ in their susceptibility possible explanation for the lack of complete correlation is provided by the data in the current study. Although by standard clinical, chemical, and intestinal morphologic criteria, no evident differences exist between patients with GSE who are HLA-B8 positive or negative, a clear difference exists with regard to sensitivity to gluten in vitro between HLA-B8 positive and negative patients. Thus, intestinal biopsies of HLA-B8 positive patients show a consistent sensitivity to gluten when tested in vitro. On the other hand, intestinal biopsies from patients who are HLA-B8 negative and clearly have gluten sensitivity in vivo, are indistinguishable from biopsies of controls, each showing no consistent sensitivity to gluten in vitro. Therefore, if used to assess the diagnosis of GSE prospectively, the usefulness of the in vitro technique can be enhanced by taking the patients' histocompatibility antigen into account.
One possible explanation for the difference between the effect of gluten in vivo and in vitro is that gluten presented to the intestinal mucosa in vivo differs from gluten presented in vitro. In fact, gluten protein is subjected to nearly complete proteolytic degradation in vivo, whereas proteolytic degradation in vitro (used to (17) indicated that gluten binds to the epithelial cell of patients with GSE. We suggest that the various intestinal immune reactions occur as a consequence of gluten binding to the epithelial cell; i.e., unbound gluten is not immunogenic, whereas bound gluten behaves as a hapten.
A possible mechanism which could account for the influence of histocompatibility antigen on tissue cytotoxicity is that the HLA gene product, itself, forms part of the target of cytotoxicity. The effector cell recognizes the target ofcytotoxicity either as a complex target composed of a closely associated, but separate modifying antigen (gluten), and the histocompatibility antigen (dual recognition), or recognizes the single modified histocompatibility antigen (gluten plus histocompatibility antigen) (modified self). There is experimental support for these possibilities in other experimental systems (18) . Using this concept in GSE, since the histocompatibility antigen itself forms a part of the target of cytotoxicity, HLA-B8 positive and negative patients could be expected to show different degrees of toxicity to gluten in vitro.
The precise mechanism ofthe cytotoxic event in GSE remains unidentified. Douglas (19) 
